McGuire, Alistair, Raikou, Maria and Kanavos, Panos 
ORCID: 0000-0001-9518-3089
(2008)
Pricing pharmaceuticals: value based pricing in what sense?
Eurohealth, 14 (2).
pp. 3-6.
ISSN 1356-1030
Abstract
Reimbursement of pharmaceuticals ought to provide both incentives for and reward innovation, as well as set a price which reflects the market value of the product. In other words reimbursement must reward both dynamic and static efficiency in the pharmaceutical sector. Within the UK a debate has emerged concerning whether the Pharmaceutical Pricing and Reimbursement Scheme, a profits based regulatory scheme, should be replaced with a value based pricing scheme. This article defines these competing reimbursement schemes and outlines their relative costs and benefits.
| Item Type: | Article |
|---|---|
| Official URL: | http://www2.lse.ac.uk/LSEHealthAndSocialCare/publi... |
| Additional Information: | © 2008 LSE Health |
| Divisions: | European Institute Social Policy LSE Health |
| Subjects: | R Medicine > RA Public aspects of medicine |
| Date Deposited: | 15 Feb 2011 15:37 |
| Last Modified: | 15 Sep 2023 13:40 |
| URI: | http://eprints.lse.ac.uk/id/eprint/32585 |
Actions (login required)
 |
View Item |
